TruBridge Faces Securities Claims Investigation
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Apr 21 2026
0mins
Should l Buy TBRG?
Source: Globenewswire
- Securities Claims Investigation: Rosen Law Firm is investigating potential securities claims against TruBridge, Inc. (NASDAQ: TBRG) for possibly issuing materially misleading business information, indicating serious governance and transparency issues within the company.
- Delayed Financial Reporting: TruBridge's Notification of Late Filing on Form 12b-25, submitted on March 17, 2026, reveals the company failed to file its Annual Report for the fiscal year ended December 31, 2025, due to the identification of errors in previously issued financial statements, which may undermine investor confidence in the company's financial health.
- Significant Stock Price Drop: Following the announcement of the delayed financial report, TruBridge's stock price fell by $1.84, or 10.5%, closing at $15.75 per share, reflecting market concerns regarding the company's future prospects.
- Class Action Preparation: Rosen Law Firm is preparing a class action against TruBridge, allowing investors to seek compensation without any out-of-pocket costs, highlighting the potential legal and financial risks the company may face.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy TBRG?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on TBRG
Wall Street analysts forecast TBRG stock price to fall
2 Analyst Rating
0 Buy
2 Hold
0 Sell
Hold
Current: 25.750
Low
21.00
Averages
22.00
High
23.00
Current: 25.750
Low
21.00
Averages
22.00
High
23.00
About TBRG
TruBridge, Inc. is a provider of healthcare solutions and services for community hospitals, their clinics and other healthcare systems. The Company’s segments are Financial Health and Patient Care. The Financial Health reporting segment focuses on providing a complete revenue cycle management (RCM) solution for all care settings, regardless of their primary healthcare information solutions provider, along with business management, consulting, managed IT services, analytics, and business intelligence. The Patient Care segment provides comprehensive acute care solutions and related services for community hospitals and their physician clinics. The Patient Care segment also offers comprehensive patient engagement and empowerment technology solutions to improve patient outcomes and engagement strategies with care providers. Its HFMA Peer Reviewed suite of RCM offerings combines visibility and transparency to enhance productivity and support the financial health of healthcare organizations.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
Investor Rights Law Firm Investigates Multiple Companies for Potential Violations
- Legal Investigation Launched: Halper Sadeh LLC is investigating Organon & Co. (NYSE:OGN) regarding its sale to Sun Pharmaceutical Industries Limited at $14.00 per share, which may involve breaches of shareholder rights.
- Shareholder Rights Protection: TruBridge, Inc. (NASDAQ:TBRG) is being sold to Inventurus Knowledge Solutions, Inc. for $26.25 per share in cash, and Halper Sadeh LLC encourages shareholders to understand their legal rights and options to ensure fair treatment.
- Merger Transaction Review: The merger between Cyclerion Therapeutics, Inc. (NASDAQ:CYCN) and Korsana Biosciences, Inc. is expected to result in Cyclerion shareholders owning approximately 1.5% of the combined company, with Halper Sadeh LLC potentially seeking increased consideration and additional disclosures.
- Investor Protection Actions: Halper Sadeh LLC represents investors globally, focusing on combating securities fraud and corporate misconduct, having successfully recovered millions for defrauded investors, highlighting its crucial role in safeguarding shareholder interests.
See More
TruBridge Faces Securities Claims Investigation
- Securities Claims Investigation: Rosen Law Firm is investigating potential securities claims against TruBridge, Inc. (NASDAQ: TBRG) due to allegations of issuing materially misleading business information, indicating significant deficiencies in the company's disclosure practices.
- Delayed Financial Reporting: On March 17, 2026, TruBridge filed a Notification of Late Filing on Form 12b-25, citing the identification of errors in previously issued financial statements as the reason for not filing its Annual Report for the fiscal year ended December 31, 2025, which could undermine investor confidence in the company's financial health.
- Stock Price Impact: Following this news, TruBridge's stock price fell by $1.84, or 10.5%, closing at $15.75 per share, reflecting market concerns regarding the company's financial transparency and management capabilities.
- Class Action Preparation: Rosen Law Firm is preparing a class action lawsuit, allowing investors to seek compensation without any out-of-pocket costs, indicating that the legal risks faced by the company could lead to further financial losses and reputational damage.
See More
Investor Rights Law Firm Investigates Multiple Companies for Potential Violations
- Investigation Focus: Halper Sadeh LLC is investigating TruBridge, Inc. (NASDAQ:TBRG) regarding its sale to Inventurus Knowledge Solutions, Inc. for $26.25 per share in cash, raising concerns about potential shareholder rights violations.
- Merger Impact: The merger between Helix Energy Solutions Group, Inc. (NYSE:HLX) and Hornbeck Offshore Services, Inc. will result in Helix shareholders owning approximately 45% of the combined entity, which may affect their voting rights and future earnings.
- Shareholder Rights Protection: Halper Sadeh LLC encourages shareholders to reach out to discuss their rights and options, offering legal services on a contingency basis, aiming to secure increased compensation and disclosures for affected investors.
- Legal Action Potential: The firm represents investors globally, focusing on securities fraud and corporate misconduct, having previously recovered millions for defrauded investors, demonstrating its strength in protecting investor rights.
See More
TruBridge Shares Surge on Acquisition Talks with Inventurus Knowledge
- Acquisition Negotiations: According to the Economic Times, Inventurus Knowledge is in advanced discussions to acquire TruBridge for approximately $600 million, with a formal announcement expected soon, potentially enhancing TruBridge's market value and investor confidence significantly.
- Financing Arrangements: IKS is negotiating for $675 million in financing with Citi, Deutsche Bank, and JPMorgan to support its all-cash acquisition offer and assist in refinancing TruBridge's debt, which will bolster the feasibility and funding security of the acquisition.
- Positive Market Reaction: TruBridge's shares surged 13% following the acquisition news, bringing its current market cap to about $300 million, indicating a strong market optimism regarding the acquisition prospects that may attract more investor interest.
- Future Outlook: TruBridge anticipates modest revenue growth in 2026 while expecting a 200 basis point improvement in adjusted EBITDA margins amid a strategic review, providing a solid foundation for integration post-acquisition.
See More
TruBridge Faces Securities Claims Investigation
- Securities Claims Investigation: Rosen Law Firm has announced an investigation into TruBridge, Inc. (NASDAQ: TBRG) due to potential issuance of materially misleading business information, which may expose shareholders to securities claims.
- Delayed Financial Reporting: On March 17, 2026, TruBridge filed a Form 12b-25 indicating its inability to timely file its Annual Report for the fiscal year ended December 31, 2025, citing the identification of errors in previously issued financial statements requiring further analysis.
- Stock Price Impact: Following this news, TruBridge's stock price fell by $1.84, or 10.5%, closing at $15.75 per share, reflecting market concerns regarding the company's financial transparency and governance.
- Legal Action Outlook: Investors may join the prospective class action without any out-of-pocket fees through a contingency fee arrangement, as Rosen Law Firm prepares to seek recovery of investor losses, emphasizing its commitment to protecting investor rights.
See More
TruBridge Delays 2025 Year-End Earnings Release
- Financial Statement Errors: TruBridge identified errors in its consolidated financial statements for the year ended December 31, 2024, and out-of-period errors for all three quarters of 2025, primarily related to revenue accounting, software development costs, and share-based payments, although these did not result in material misstatements, necessitating additional audit time.
- Earnings Release Postponed: The company announced the postponement of its fourth-quarter and year-end 2025 earnings release originally scheduled for March 16, 2026, indicating a cautious approach to completing its audit procedures, with expectations to file by March 31, 2026.
- Stock Price Reaction: Following the announcement, TruBridge's shares fell over 5%, reflecting market concerns regarding financial transparency and the delay in auditing, with a total decline of 25% in 2026 thus far.
- Market Sentiment: Despite the stock decline, retail sentiment around TruBridge remains neutral amid high message volume, indicating investor focus on the company's future financial health and performance expectations.
See More
Investor Rights Law Firm Investigates Multiple Companies for Potential Violations
- Legal Investigation Launched: Halper Sadeh LLC is investigating Organon & Co. (NYSE:OGN) regarding its sale to Sun Pharmaceutical Industries Limited at $14.00 per share, which may involve breaches of shareholder rights.
- Shareholder Rights Protection: TruBridge, Inc. (NASDAQ:TBRG) is being sold to Inventurus Knowledge Solutions, Inc. for $26.25 per share in cash, and Halper Sadeh LLC encourages shareholders to understand their legal rights and options to ensure fair treatment.
- Merger Transaction Review: The merger between Cyclerion Therapeutics, Inc. (NASDAQ:CYCN) and Korsana Biosciences, Inc. is expected to result in Cyclerion shareholders owning approximately 1.5% of the combined company, with Halper Sadeh LLC potentially seeking increased consideration and additional disclosures.
- Investor Protection Actions: Halper Sadeh LLC represents investors globally, focusing on combating securities fraud and corporate misconduct, having successfully recovered millions for defrauded investors, highlighting its crucial role in safeguarding shareholder interests.
See More
TruBridge Faces Securities Claims Investigation
- Securities Claims Investigation: Rosen Law Firm is investigating potential securities claims against TruBridge, Inc. (NASDAQ: TBRG) due to allegations of issuing materially misleading business information, indicating significant deficiencies in the company's disclosure practices.
- Delayed Financial Reporting: On March 17, 2026, TruBridge filed a Notification of Late Filing on Form 12b-25, citing the identification of errors in previously issued financial statements as the reason for not filing its Annual Report for the fiscal year ended December 31, 2025, which could undermine investor confidence in the company's financial health.
- Stock Price Impact: Following this news, TruBridge's stock price fell by $1.84, or 10.5%, closing at $15.75 per share, reflecting market concerns regarding the company's financial transparency and management capabilities.
- Class Action Preparation: Rosen Law Firm is preparing a class action lawsuit, allowing investors to seek compensation without any out-of-pocket costs, indicating that the legal risks faced by the company could lead to further financial losses and reputational damage.
See More
Investor Rights Law Firm Investigates Multiple Companies for Potential Violations
- Investigation Focus: Halper Sadeh LLC is investigating TruBridge, Inc. (NASDAQ:TBRG) regarding its sale to Inventurus Knowledge Solutions, Inc. for $26.25 per share in cash, raising concerns about potential shareholder rights violations.
- Merger Impact: The merger between Helix Energy Solutions Group, Inc. (NYSE:HLX) and Hornbeck Offshore Services, Inc. will result in Helix shareholders owning approximately 45% of the combined entity, which may affect their voting rights and future earnings.
- Shareholder Rights Protection: Halper Sadeh LLC encourages shareholders to reach out to discuss their rights and options, offering legal services on a contingency basis, aiming to secure increased compensation and disclosures for affected investors.
- Legal Action Potential: The firm represents investors globally, focusing on securities fraud and corporate misconduct, having previously recovered millions for defrauded investors, demonstrating its strength in protecting investor rights.
See More
TruBridge Shares Surge on Acquisition Talks with Inventurus Knowledge
- Acquisition Negotiations: According to the Economic Times, Inventurus Knowledge is in advanced discussions to acquire TruBridge for approximately $600 million, with a formal announcement expected soon, potentially enhancing TruBridge's market value and investor confidence significantly.
- Financing Arrangements: IKS is negotiating for $675 million in financing with Citi, Deutsche Bank, and JPMorgan to support its all-cash acquisition offer and assist in refinancing TruBridge's debt, which will bolster the feasibility and funding security of the acquisition.
- Positive Market Reaction: TruBridge's shares surged 13% following the acquisition news, bringing its current market cap to about $300 million, indicating a strong market optimism regarding the acquisition prospects that may attract more investor interest.
- Future Outlook: TruBridge anticipates modest revenue growth in 2026 while expecting a 200 basis point improvement in adjusted EBITDA margins amid a strategic review, providing a solid foundation for integration post-acquisition.
See More
TruBridge Faces Securities Claims Investigation
- Securities Claims Investigation: Rosen Law Firm has announced an investigation into TruBridge, Inc. (NASDAQ: TBRG) due to potential issuance of materially misleading business information, which may expose shareholders to securities claims.
- Delayed Financial Reporting: On March 17, 2026, TruBridge filed a Form 12b-25 indicating its inability to timely file its Annual Report for the fiscal year ended December 31, 2025, citing the identification of errors in previously issued financial statements requiring further analysis.
- Stock Price Impact: Following this news, TruBridge's stock price fell by $1.84, or 10.5%, closing at $15.75 per share, reflecting market concerns regarding the company's financial transparency and governance.
- Legal Action Outlook: Investors may join the prospective class action without any out-of-pocket fees through a contingency fee arrangement, as Rosen Law Firm prepares to seek recovery of investor losses, emphasizing its commitment to protecting investor rights.
See More
TruBridge Delays 2025 Year-End Earnings Release
- Financial Statement Errors: TruBridge identified errors in its consolidated financial statements for the year ended December 31, 2024, and out-of-period errors for all three quarters of 2025, primarily related to revenue accounting, software development costs, and share-based payments, although these did not result in material misstatements, necessitating additional audit time.
- Earnings Release Postponed: The company announced the postponement of its fourth-quarter and year-end 2025 earnings release originally scheduled for March 16, 2026, indicating a cautious approach to completing its audit procedures, with expectations to file by March 31, 2026.
- Stock Price Reaction: Following the announcement, TruBridge's shares fell over 5%, reflecting market concerns regarding financial transparency and the delay in auditing, with a total decline of 25% in 2026 thus far.
- Market Sentiment: Despite the stock decline, retail sentiment around TruBridge remains neutral amid high message volume, indicating investor focus on the company's future financial health and performance expectations.
See More
